Clinical Trials List
2024-02-26 - 2026-07-28
Phase III
Not yet recruiting1
Terminated7
-
Trial Applicant
ELI LILLY AND COMPANY(TAIWAN), INC.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- 方姿蓉 無
- Hsiang Chun Lee 無
- Wei-Chung Tsai 無
- Mei Yueh Lee 無
- Po-Chao Hsu 無
- 吳韋璁 無
- 洪薇雯 無
- Chun-Yuan Chu 無
- 卓士傑 無
- Ye-Hsu Lu 無
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- CHIH-YUAN WANG CHIH-YUAN WANG 無
- Kuo-Chin Huang 無
- 張皓翔 無
- 謝易庭 無
- 張恬君 無
- 賴瑩純 無
- 吳婉禎 無
- 盧佳文 無
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Chern-En Chiang 醫學研究部
- 李慶威 無
- 黃少嵩 無
- 蔡依霖 無
- 游偉光 無
- Tze-Fan Chao 無
- 吳承學 無
- 郭泠 無
- 廖若男 無
- Tse-Min Lu 無
- Wen-Chung Yu 無
- 張俊欽 無
- 黃偉銘 無
- Hao-min Cheng 無
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
888 participants
-
Global
80-120 participants
